[Translation] A multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial to evaluate the efficacy and safety of Yisui Shengxue Granules in the treatment of non-transfusion-dependent thalassemia
评价益髓生血颗粒治疗非输血依赖型地中海贫血(脾肾两虚、精血不足证)的有效性和安全性,同时对量-效关系进行探索,为Ⅲ期临床试验设计提供数据支持。
[Translation] To evaluate the efficacy and safety of Yisui Shengxue Granule in the treatment of non-transfusion-dependent thalassemia (deficiency of both spleen and kidney, deficiency of essence and blood), and to explore the dose-effect relationship, so as to provide data support for the design of Phase III clinical trials.